Novel biomarkers are identified using a combination of multi-omics approaches, analytical protocols for quantification and computational approaches for data processing and statistical analysis. The biomarker targets include DNA, RNA, epigenetics, lipids, metabolites or proteins.
Confirmation on the discovered biomarkers is achieved using a wide array of analytical technologies together with high accuracy and high sensitivity mass spectrometry coupled to liquid chromatography, photoionization and electrochemistry.
